We have located links that may give you full text access.
Methods of assessing the impact of congenital rubella infection.
Reviews of Infectious Diseases 1985 March
Monitoring of congenital rubella infection (CRI) involves measuring the assessable outcomes of infection of the pregnant woman. These assessable outcomes are infection itself, therapeutic abortion, and birth of infants with congenital rubella syndrome (CRS). The incidence of infections can be estimated with use of data on age-specific occurrence of acquired rubella or acquisition of antibody in females and on fertility rates. The incidence of CRS can be estimated from data on infections of pregnant women and reports in the literature of incidence rates of CRS among infants born of infected mothers. Surveillance of CRS can involve individual case detection or serosurveys among populations with defects characteristic of CRS, such as deafness, and among comparison groups. To assess the impact of CRI, countries without rubella control programs should estimate the frequency of infections in pregnant women from existing surveillance data or determine by serosurveys the susceptibility and/or age-specific acquisition of rubella antibody in postpubertal females. Countries with rubella control programs should monitor cases of acquired rubella and/or prevalence of seropositivity in postpubertal females, therapeutic abortions, and CRS to assess effectiveness of the program and to determine high-risk populations that should be targets of intense vaccination programs.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app